Showing results (41-50 of 646) with videos related to
Sort By:
Pageof 65
British Journal of Haematology|January 3, 2024
Early detection of multiple myeloma: A first step towards a screening programmeChristof Scheid, Ola LandgrenClinical Advances in Hematology & Oncology : H&O|November 16, 2019
Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime timeDickran Kazandjian, Ola LandgrenSeminars in Oncology|January 8, 2017
A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survivalDickran Kazandjian, Ola LandgrenBest Practice & Research. Clinical Haematology|November 10, 2016
Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemiaSham Mailankody, Ola LandgrenAdvances in Therapy|June 16, 2023
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A PodcastOla Landgren, Omar NadeemLeukemia & Lymphoma|January 8, 2013
Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging "early myeloma"Jens Hillengass, Ola LandgrenBlood Cancer Discovery|September 1, 2023
MRD and Plasma Cell Dynamics after CAR T-cell Therapy in MyelomaOla Landgren, Dickran KazandjianBlood|December 3, 2021
Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccinationYair Herishanu, Galia Rahav, Shai Levi, et al.American Journal of Hematology|August 12, 2014
Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study GroupTamar Tadmor, Lev Shvidel, Osnat Bairey, et al.Anticancer Research|February 11, 2014
Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study groupTamar Tadmor, Lev Shvidel, Neta Goldschmidt, et al.Pageof 65